D2R News
Stay informed about D2R updates by subscribing to our mailing list!
平特五不中
On this page, you will find press releases, media coverage, newsletters, and annual reports, among others, allowing you to follow D2R鈥檚 latest news. For all interview or information requests from media representatives, please contact D2R.comms [at] mcgill.ca .听
Press Releases
-
D2R announces new round of funding, investing $1.5 million to advance research in RNA therapeutics and to support 平特五不中 Centres and Institutes (December 2024)
-
CQDM partners with D2R to enhance collaborations among researchers and industry in RNA research听(November 2024)
-
Philippe Gros appointed Chief Scientific Officer of D2R听(October 2024)
-
D2R welcomes RNA and genomic researchers to Universit茅 de Sherbrooke (October 2024)
-
G茅nome Qu茅bec invests up to $500,000 to boost RNA therapeutics innovation in Quebec (October 2024)
-
D2R awards $7.3 million to Advance Research in Genomic-Based RNA Therapeutics (September 2024)
-
$165-million for 平特五不中鈥檚 world-leading inclusive genomics and RNA research program (础辫谤颈濒听2023)
Media coverage
- (LeDevoir, March 2024)
- (Innovation News Network, February 2024)
- (Maclean's, December 2023)
- (University World News, May 2023)
- (CTV News, April 2023)
- 听(Government of Canada, April 2023)
D2R Newsletters
听
Reports & Factsheets
- 平特五不中's 2023 Annual Report on Research and Innovation. D2R is mentioned on pages 10-12.
- D2R Factsheet
- D2R Booklet
听
